Search company, investor...

Founded Year

2018

Stage

Series C | Alive

Total Raised

$643M

Last Raised

$400M | 4 yrs ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

-79 points in the past 30 days

About Insitro

Insitro focuses on drug discovery and development. The company's main services involve the use of machine learning and high-throughput biology to predict successful paths for medicine creation. It aims to avoid costly failures in pharmaceutical research and development (R&D). Insitro primarily sells to the healthcare industry. It was founded in 2018 and is based in South San Francisco, California.

Headquarters Location

279 East Grand Avenue Suite 200

South San Francisco, California, 94080,

United States

Loading...

ESPs containing Insitro

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare & Life Sciences / Drug R&D Tech

The generative AI — protein & drug design tools market offers solutions that aim to accelerate and de-risk the drug development process. By using generative AI, companies can significantly reduce the time and cost of drug discovery, expedite the development cycle to design next-generation therapeutics and vaccines, and engineer proteins with fewer experiments. These technologies can increase the a…

Insitro named as Highflier among 15 other companies, including Insilico Medicine, Cradle, and InstaDeep.

Insitro's Products & Differentiators

    Statistical genetics

    ML-enabled statistical genetics to discover targets and patient segments

Loading...

Expert Collections containing Insitro

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Insitro is included in 6 Expert Collections, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,244 items

A

AI 100

200 items

A

Artificial Intelligence

14,769 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.

D

Digital Health 50

300 items

The most promising digital health startups transforming the healthcare industry

D

Digital Health

11,068 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

D

Drug Discovery Tech Market Map

221 items

This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.

Insitro Patents

Insitro has filed 18 patents.

The 3 most popular patent topics include:

  • biotechnology
  • molecular biology
  • bioinformatics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/11/2023

7/23/2024

Transcription factors, Stem cells, Developmental biology, Induced stem cells, Biotechnology

Grant

Application Date

8/11/2023

Grant Date

7/23/2024

Title

Related Topics

Transcription factors, Stem cells, Developmental biology, Induced stem cells, Biotechnology

Status

Grant

Latest Insitro News

Leading AI Companies Revolutionizing Various Industries

Jul 5, 2024

Leading artificial intelligence companies revolutionizing industries with cutting-edge innovations 05 Jul 2024, 1:30 pm Artificial Intelligence (AI) stands as a transformative force across industries, reshaping how businesses operate and pushing the boundaries of what technology can achieve. Leading this revolution are a handful of companies, each driving cutting-edge innovation within their specific sectors using some form of AI. These companies are not only charting the way for tomorrow but also re-writing the concept of what our future will be, from advancing data analytics and transforming pharmaceutical research to innovating defense technology and pushing practical robotics further than ever. Here, we delve into the groundbreaking contributions of eight leading AI companies that are transforming industries worldwide. OpenAI: Pioneering Generative AI and Language Models In the world of AI, OpenAI is a giant name and is reputed for its deep generative capabilities with state-of-the-art models. Its language model, such as GPT-4, is well-known for its ability to understand and generate human-like text. Some use cases of these models include auto-replies for customer service, generating content and text analysis. The technology is used by financial institutions for predictive analytics, risk evaluation and other purposes related to AI, as well as by government entities seeking the processing of vast amounts of data using AI applications. Anthropic: Advancing AI Research and Development Another key figure in the AI space is Anthropic, which has done a great deal of work on research and development in AI . The company partners with consulting and financial firms to build advanced AI tools. Anthropic , as a result of its emphasis on creating AI systems that are trustworthy, interpretable and aligned with human values, also safeguards this reputation, by making sure that its innovations are ethically sound. There will likely be a growing need in industries that heavily rely on AI for responsible and ethical use. Databricks: Transforming Data Analytics and AI Deployment Databricks focuses on data analytics and AI deployment software, catering to clients as wide-ranging as those found in energy and government services. The company's Enterprise Data Platform allows enterprises to easily extract meaning from structured and unstructured data, resulting in new analytics and machine learning capabilities. The offering of Databricks enables industry use cases including optimising resource management and predictive maintenance combined with strengthened operational awareness in the energy sector and enhanced data-driven decision-making capabilities for government use. Cohere: Leading in Natural Language Processing Cohere aims to push the discipline of natural language processing (NLP), a subset of AI that is critical for interpreting and producing human-like text. The firm's innovations in NLP are particularly important for automated translation, sentiment analysis, and conversational AI . Cohere is increasing technological accessibility and friendliness by enabling machines to understand and respond more naturally, allowing humans to communicate better with the technology on which they all rely. Mistral AI: Innovating Across the AI Landscape Mistral AI is recognized for producing new advancements in the overall landscape of artificial intelligence. The company has been building a diverse AI toolkit, from improving machine learning algorithms to brand new AI-driven products. The innovations from Mistral AI are applied in numerous verticals that allow enterprises to benefit from AI, resulting in a competitive advantage. Mistral AI is pushing the limitations of what can be achieved with technology and setting new benchmarks in industry standards for advanced applications using AI. Anduril: Revolutionizing Defense Technology Anduril manufactures Defense technology, like AI-powered security and surveillance. The company offers AI-powered defence related solutions that increase situational awareness, automate threat detection and improve decision making during defense operations. Military and defence agencies rely on Anduril’s technology to secure the nation, showcasing how AI has come a long way since being rooted in defense strategies centuries ago. Insitro: Transforming Drug Discovery with AI Insitro is changing the future of pharmacology through machine learning for drug predictions. By applying AI to this aspect of drug discovery, the company can hasten the identification of potential drugs capable of fighting a targeted disease and cut down substantially on traditional resources that are invested in unproductive areas. The technologies of Insitro are disruptive in personalized medicine, where AI can help do things like tailor prescriptions to individual patients based on their genetics. This combination revolving AI and biology is expected to be a fruitful measure for the advancement of medical science as it will have implications in improving patient outcomes. Figure AI: Pushing the Boundaries of Robotics Figure AI is pushing the boundaries of AI in robotics, working on creating humanoid robots that have the potential to transform the future of automation. They were created to replicate the tasks meant for humans: manufacturing, logistics and personal assistance. With ever more capable robots, they have the opportunity to build technology that can perceive and act on its environment autonomously, which is an essential step towards personalized automation in a range of industries. Conclusion From disrupting industries to creating entirely new markets, the breakthroughs these leading AI companies are uncovering will push boundaries and continually define our futures. Leading AI companies such as OpenAI, Anthropic, Databricks, Cohere and Mistral AI are driving this transformation by leveraging very unique inventions in the field of Artificial Intelligence with others applying revolutionary techniques to problems that remained mostly untapped until now. As these innovations mature and adapt, AI will increasingly adapt to different changes in the world to offer fresh chances and remedy some of modern society's most urgent issues. AI has great potential and these companies are making sure that the future of AI goes in the right direction.

Insitro Frequently Asked Questions (FAQ)

  • When was Insitro founded?

    Insitro was founded in 2018.

  • Where is Insitro's headquarters?

    Insitro's headquarters is located at 279 East Grand Avenue, South San Francisco.

  • What is Insitro's latest funding round?

    Insitro's latest funding round is Series C.

  • How much did Insitro raise?

    Insitro raised a total of $643M.

  • Who are the investors of Insitro?

    Investors of Insitro include Two Sigma Ventures, Andreessen Horowitz, ARCH Venture Partners, Third Rock Ventures, Foresite Capital and 15 more.

  • Who are Insitro's competitors?

    Competitors of Insitro include Noetik, Exscientia, Healx, Celsius Therapeutics, Zephyr AI and 7 more.

  • What products does Insitro offer?

    Insitro's products include Statistical genetics and 2 more.

Loading...

Compare Insitro to Competitors

Atomwise Logo
Atomwise

Atomwise develops machine learning-based discovery engines and uses artificial intelligence (AI)--based neural networks to help discover new medicines. It predicts drug candidates for pharmaceutical companies, start-ups, and research institutions and designs drugs using computational drug design. It was formerly known as Chematria. The company was founded in 2012 and is based in San Francisco, California.

Healx Logo
Healx

Healx is a technology company focused on artificial intelligence (AI) drug discovery for rare disease treatment within the pharmaceutical industry. The company specializes in using AI to identify drug-disease relationships and accelerate the development of new therapies for rare conditions. Healx's approach aims to increase the scale and success rate of rare disease treatment development by repurposing known compounds and running multiple drug discovery programs in parallel. Healx was formerly known as Healx3. It was founded in 2014 and is based in Cambridge, United Kingdom.

A
Aria Pharmaceuticals

Aria Pharmaceuticals operates as a preclinical-stage pharmaceutical company that focuses on the discovery and development of novel, small-molecule therapies in the pharmaceutical industry. The company's main service is the development of new treatments for complex and hard-to-treat diseases using its proprietary symphony platform, which combines biomedical data and artificial intelligence to increase the success rates of drug discovery. Aria Pharmaceuticals primarily serves the healthcare sector, specifically targeting areas where new therapies are most needed. It was founded in 2014 and is based in Palo Alto, California.

Standigm Logo
Standigm

Standigm is an AI-driven drug discovery company operating in the pharmaceutical industry. The company's main services include the use of proprietary AI platforms for novel target identification, lead generation, and the creation of commercially valuable drug pipelines. Standigm primarily sells to the pharmaceutical and healthcare industries. It was founded in 2015 and is based in Seoul, South Korea.

Aitia Logo
Aitia

Aitia is a company focused on the development and application of Causal AI and Digital Twins in the pharmaceutical industry. The company's main services include the discovery of drugs for neurodegenerative disorders, oncology, and immunology by revealing hidden biological mechanisms of diseases and creating Digital Twins. These Digital Twins are used to discover novel therapies and accelerate research and development in various diseases such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, multiple myeloma, prostate cancer, and pancreatic cancer. It was founded in 2000 and is based in Cambridge, Massachusetts.

BioMap Logo
BioMap

BioMap focuses on leveraging artificial intelligence (AI) to advance life sciences. The company develops AI Foundation Models to understand and predict biological behaviors and creates task models for various life science applications, including therapeutic antibodies and industrial enzymes. BioMap primarily serves the biotechnology and pharmaceutical industries with its AI-driven solutions. It was founded in 2020 and is based in Palo Alto, California.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.